Michael Theisen

Title: Innovations by Inventor Michael Theisen

Introduction: Michael Theisen is a notable inventor located in Frederiks Ber GC, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of novel vaccines.

Latest Patents: Michael Theisen holds a patent for "Nucleic acid molecules encoding Haemophilus somnus proteins." This groundbreaking patent discloses novel vaccines aimed at preventing and treating H. somnus infections. The vaccines feature epitopes derived from proteins LppA, LppB, LppC, or combinations thereof. Additionally, the patent includes details on nucleotide sequences encoding these lipoproteins, vectors containing these sequences, and host cells that have been transformed with these vectors.

Career Highlights: Michael Theisen is currently affiliated with the University of Saskatchewan, where he focuses on advancing research in immunology and vaccine development. His innovative work positions him as a key figure in addressing infectious diseases.

Collaborations: Throughout his career, Michael has collaborated with esteemed colleagues, including Andrew A. Potter and Richard J. Harland. These partnerships have fostered a collaborative research environment, enhancing the pursuit of innovative solutions in the field.

Conclusion: Michael Theisen's contributions to vaccine development illustrate the vital role of inventors in addressing healthcare challenges. With his patent on a novel vaccine aimed at H. somnus infections, he continues to push the boundaries of scientific innovation. As research progresses, the impact of his work is likely to be felt in the broader medical community and beyond.